LATEST ALERTS
This week’s regulatory news in brief includes updates from Belgium, the EU France, Poland, Romania, Spain the US, Costa Rica, Guyana and Indonesia
The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.
Two German parliamentary groups have submitted a joint initiative to remove industrial hemp from the Narcotics Act and raise the THC limit from 0.2% to at least 0.6%
This report examines the current rules for US interstate transportation, covering documentation needed as well as individual courier rules
This week’s regulatory news in brief includes updates from Bosnia and Herzegovina, France, Germany, Ireland, Italy, Netherlands, Poland, the US, Brazil, Costa Rica, Thailand and Uruguay
A proposal to legalise low-THC hemp was submitted on 19th January in the Korean parliament, which proposes to exclude synthetic products as well as preparations with THC content up to 0.3% from cannabis
This week’s regulatory news in brief includes updates from the EU, France, Italy, Netherlands, Mexico, the US, Australia, China, Japan and Uruguay
Uzbekistan has published a regulatory framework to implement its legalisation of industrial hemp farming and production passed last year
Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt and target any company using a CO2 method that it believes infringes on its intellectual property (IP). There does appear to be » Continue Reading.
This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states’ regulations as possible
Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear
A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country
CBD-Intel presents some predictions of what regulatory moves could take place around cannabis, hemp and CBD in the US in 2021
Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework
A recently published report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) highlights the diverse retail make-up and unclear regulatory outlook of the European CBD sector
This week’s regulatory news in brief includes updates from the UK, Trinidad & Tobago, the US, Argentine, Australia, Philippines and Ukraine
President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in the state of Georgia give Democrats 48 seats with two independents that generally vote democratic (and would certainly do so on most » Continue Reading.
Reform of cannabis laws at federal level in the US looks to be a step closer following the likely victory of the Democratic party in run-off elections for both Senate seats in the state of Georgia
South Dakota’s governor has put public cash behind a legal challenge to a move – backed by a majority of voters – to legalise recreational cannabis in the US state. But can the lawsuit overturn the vote?
Further CBD regulations in the US could be based on rules proposed in the state of New York, it has been suggested – especially crucial definitions for some key terms
For many 2020 will always carry an asterisk. The CBD industry was – overall – more fortunate than many other sectors
Multiple jurisdictions are planning significant legislation on both CBD and hemp-related matters, but it seems regulation in 2021 could be defined as much by what doesn’t happen as by the progress made
Efforts to supply the first CBD product to Brazil’s public healthcare system will have to wait a while longer – and there is some dispute between the institute preparing to produce it and the sponsors of a Congress bill
This week’s regulatory news in brief includes updates from the UE, Iceland, Ireland, Italy, Lithuania, the UK, Ukraine, the US, Australia and Thailand
This week’s regulatory news in brief includes updates from Belgium, France, Ireland, Italy, Netherlands, Switzerland, Bermuda, the British Virgin Islands, Canada, Guam, the US, Australia, Brazil, Philippines, Thailand and Uzbekistan
Cannabis legalisation is so far away in Russia that the plant is now considered a national security threat, according to provisions of the new state strategy for Anti-Drug Policy.
The Italian Customs Agency is trying to widen its jurisdiction by proposing including the sale of CBD hemp flowers within the state monopoly. Others have similar ideas
A proposed amendment to Polish law would ban the sale of CBD products through vending machines – but one company using that distribution method does not see any reason to stop just yet
CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place
The implications of the Kanavape ruling could be far-reaching. This report examines the decision by the Court of Justice of the European Union (CJEU) and some of its likely consequences
This week’s regulatory news in brief includes updates from North Macedonia, Switzerland, Mexico, the US, British Virgin Islands, Ecuador, Israel, New Zealand and Thailand
The European Parliament will have a united position on hemp-related issues during the ongoing tripartite negotiations, which must be concluded by the end of March
The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a baseline level of requirements and » Continue Reading.
This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis
Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland
A move to legalise cannabis in the US state of Montana, backed by a substantial majority in last month’s ballot, is under threat from a legal bid to block it
This week’s regulatory news in brief includes updates from Belgium, Cyprus, the EU, Denmark, France, Ireland, Italy, Slovakia, Spain, the US, Colombia, Costa Rica, New Zealand and Thailand
The European Commission (EC) will start to review novel food applications after reversing its opinion on the narcotic status of CBD, the EC has confirmed to CBD-Intel
The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their favour at the Court of Justice of the European Union, United Nations and now the EC. The resumption of novel food assessment » Continue Reading.
The United Nations (UN) vote on various cannabis related proposals has largely been seen as a historic moment symbolically but one that can only be considered a tiny first step in practical terms
A CBD shop in the town of Glastonbury in southwest England has been called out for publishing anti-mask advertisements
One of four proposed changes to the international scheduling of cannabis as well as CBD has been passed by the 53 voting members of the United Nations Commission on Narcotic Drugs (CND)
The Isle of Man looks likely to become the second jurisdiction operating under UK regulations to allow the use of hemp flowers in extraction
The following is a historical compilation of the updates to the US CBD delta-8 tracker from June 2022 to present. Click on each date to expand the list of updates for that month.
Italian legislators have put forward another proposal that has yet to be presented as an amendment to regulate the CBD sector and, in particular, the sale of flowers, finished products and extracts
This week’s regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy, Lithuania, Netherlands, Poland, Spain, the US, Israel, South Africa, Thailand and Zimbabwe
Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in the US where Black Friday – » Continue Reading.
Officials in Malawi have been accused of deliberately setting high licence fees for hemp and cannabis cultivation and trade in order to attract international investment and exclude local ownership
Starting next year, Switzerland will allow the commercial growing of all hemp varieties with a THC content below 1% – even those that are not in the European Union catalogue
Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
